-+ 0.00%
-+ 0.00%
-+ 0.00%

KYNTRA BIO ANNOUNCES POSITIVE DATA FROM THE INVESTIGATOR-SPONSORED PHASE 1B/2 STUDY OF FG-3246 IN COMBINATION WITH ENZALUTAMIDE IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER TO BE PRESENTED AT ASCO GU 2026

Reuters·02/23/2026 22:10:00

Please log in to view news